Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Sol-Gel Technologies Logo
Sol-Gel Technologies Growth Score
74
CB Rank
172502
Heat Score
60
Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals.
Acquired by
Arkin Capital Logo
Arkin Capital
Founded
obfuscation
PublicPost-IPO Equity Nes Ziyyona, HaMerkaz, Israel51-100 www.sol-gel.com/
Biotechnology
Pharmaceutical
Overview

Sol-Gel Technologies
Total Funding
obfuscation
Growth Score
74
Heat Score
60

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score74
-3 pts
in past quarter
Heat Score 60
-23 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Sol-Gel Technologies

CB Rank
172502
Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals.
Acquired by
Arkin Capital Logo
Arkin Capital
Founded
obfuscation
PublicPost-IPO Equity Nes Ziyyona, HaMerkaz, Israel51-100 www.sol-gel.com/
Biotechnology
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Sub-Organization of 
Yissum Technology Transfer Company of the Hebrew University Logo
Yissum Technology Transfer Company of the Hebrew University
Operating Status Active
Stock Symbol  NASDAQ:SLGL
Company Type For Profit
Founders  Alon Seri-Levy
About the Company
Sol-Gel designs and delivers innovative dermatological drugs ranging from completely non-leachable to highly-controlled-release of unique formulations and compounds.
Phone Number 972 8 931 3433
Contact Email mori@arkinholdings.com
Predictions & Insights

Growth Insight

See this Growth Insight
Sol-Gel Technologies is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

SGT-610 (Patidegib Gel)
A topical gel designed to prevent new basal cell carcinoma lesions, primarily for patients with Gorlin syndrome.
TWYNEO
A fixed-dose topical cream combining tretinoin and benzoyl peroxide for treating acne vulgaris in patients aged nine and older.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Sol-Gel Technologies Logo
Post-IPO Equity - Sol-Gel Technologies
7
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sol-Gel Technologies Logo
Post-IPO Equity - Sol-Gel Technologies
7
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sol-Gel Technologies Logo
Post-IPO Equity - Sol-Gel Technologies
7
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sol-Gel Technologies Logo
Post-IPO Equity - Sol-Gel Technologies
7
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sol-Gel Technologies Logo
Post-IPO Equity - Sol-Gel Technologies
7
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Sol-Gel Technologies Logo
Post-IPO Equity - Sol-Gel Technologies
7
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sol-Gel Technologies Logo
Post-IPO Equity - Sol-Gel Technologies
7
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sol-Gel Technologies Logo
Post-IPO Equity - Sol-Gel Technologies
7
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sol-Gel Technologies Logo
Post-IPO Equity - Sol-Gel Technologies
7
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sol-Gel Technologies Logo
Post-IPO Equity - Sol-Gel Technologies
7
obfuscation
— Post-IPO Equity

Investors

M&A Details

Sol-Gel Technologies was acquired by Arkin Capital on
obfuscation
.
Transaction Name 
Sol-Gel Technologies acquired by Arkin Capital Logo
Sol-Gel Technologies acquired by Arkin Capital
Acquired by 
Arkin Capital Logo
Arkin Capital
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 1 Contacts 13

Employee Profiles

News

News and Press

News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 17, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 17, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,025
154.72%
 in past month

Interest Signals

TopicSurge Score
Security Patches Logo
Security Patches
69
Patch Logo
Patch
69
Patch Management Logo
Patch Management
69

Actively Used Products

13Sol-Gel Technologies uses 13 technology products and services including HTML5, Lightbox, and  Vimeo, according to G2 Stack.

Active Website Tech Count

11Sol-Gel Technologies is actively using 11 technologies for its website, according to BuiltWith. These include Pound Sterling, Japanese Yen, and  Drupal.

Total IP

111The intellectual property of Sol-Gel Technologies includes 88 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Sol-Gel Technologies has registered 23 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Sol-Gel Technologies's headquarters? Sol-Gel Technologies is located in Nes Ziyyona, HaMerkaz, Israel.Who invested in Sol-Gel Technologies? Sol-Gel Technologies has 8 investors including Squadron Capital Management and  Affinity Asset Advisors.When was the last funding round for Sol-Gel Technologies? Sol-Gel Technologies closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Sol-Gel Technologies's competitors? Alternatives and possible competitors to Sol-Gel Technologies may include IBSA, Humanis, and  Amman Pharmaceutical Industries.How much funding has Sol-Gel Technologies raised to date? Sol-Gel Technologies has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f7db04b 1)
|